Moreover, NDV is replicated within the AN3 tumor mass for many cycles after intratumoral injection, which leads to activation of caspase-3 in cancer cells (Hickey et al., 2013); therefore, this mechanism reduces tumor volume and enhances the antitumor efficacy of NDV. This evidence concerns the gene CASP3 and neoplasm.